GH Guardant Health, Inc. Stock Quote

GH [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-1.91	Insider Own	6.00%	Shs Outstand	99.55M	Perf Week	1.69%
Market Cap	16.00B	Forward P/E	-	EPS next Y	-1.62	Insider Trans	-59.58%	Shs Float	92.53M	Perf Month	27.31%
Income	-185.20M	PEG	-	EPS next Q	-0.57	Inst Own	79.60%	Short Float	4.03%	Perf Quarter	59.01%
Sales	271.30M	P/S	58.96	EPS this Y	15.70%	Inst Trans	-7.83%	Short Ratio	3.62	Perf Half Y	95.65%
Book/sh	10.97	P/B	14.77	EPS next Y	28.20%	ROA	-16.70%	Target Price	150.20	Perf Year	91.54%
Cash/sh	10.27	P/C	15.78	EPS next 5Y	12.60%	ROE	-19.50%	52W Range	55.90 - 168.52	Perf YTD	25.74%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-10.10%	52W High	-3.83%	Beta	-
Dividend %	-	Quick Ratio	14.70	Sales past 5Y	-	Gross Margin	68.30%	52W Low	189.91%	ATR	6.41
Employees	622	Current Ratio	15.10	Sales Q/Q	22.70%	Oper. Margin	-69.90%	RSI (14)	75.77	Volatility	3.99% 4.81%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-469.10%	Profit Margin	-68.30%	Rel Volume	0.98	Prev Close	163.34
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 05 AMC	Payout	-	Avg Volume	1.03M	Price	162.06
Recom	1.30	SMA20	15.03%	SMA50	27.42%	SMA200	63.02%	Volume	1,009,249	Change	-0.78%

Jan-11-21

Initiated

Stifel

Buy

$175

Sep-09-20

Initiated

Morgan Stanley

Overweight

$110

Jun-12-20

Initiated

BTIG Research

Buy

Feb-21-20

Initiated

Guggenheim

Buy

$103

Jan-07-20

Initiated

Citigroup

Buy

$100

Aug-07-19

Reiterated

Canaccord Genuity

Buy

$96 → $125

Apr-16-19

Initiated

Canaccord Genuity

Buy

$90

Apr-10-19

Upgrade

BofA/Merrill

Neutral → Buy

$81 → $84

Feb-28-19

Reiterated

BofA/Merrill

Neutral

$42 → $60

Oct-29-18

Initiated

William Blair

Outperform

Oct-29-18

Initiated

JP Morgan

Overweight

$42

Oct-29-18

Initiated

BofA/Merrill

Neutral

$37

Jan-18-21 03:00AM	Guardant Health and Vall dHebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe Business Wire
Jan-14-21 08:05AM	Guardant Health to Present Data at ASCO Gastrointestinal Cancers Symposium Showing Value of Liquid Biopsy to Advance Precision Oncology in Early to Late-Stage Colorectal Cancer Business Wire
Jan-13-21 07:25AM	The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations Benzinga
Jan-07-21 01:18PM	12 Best Telemedicine Stocks to Buy Now Insider Monkey +6.81%
Jan-06-21 02:47AM	What Type Of Shareholders Make Up Guardant Health, Inc.'s (NASDAQ:GH) Share Registry? Simply Wall St.
Dec-30-20 04:03PM	Guardant Health to Participate in the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-27-20 07:31AM	The 3 Best Healthcare Stocks to Buy for 2021 Motley Fool
Dec-24-20 10:21AM	Stocks This Hot Goldman Sachs Fund Likes Besides Amazon, Apple, Netflix Investor's Business Daily
Dec-18-20 06:04AM	3 High-Growth Stocks That'll Make You Richer in 2021 and Beyond Motley Fool
Dec-15-20 02:35PM	Is GH A Good Stock To Buy Now? Insider Monkey
Dec-11-20 05:00PM	Guardant Health Names Michael Bell as New Chief Financial Officer Business Wire
Dec-08-20 12:32PM	Is Guardant Health (GH) a Smart Long-term Buy? Insider Monkey
08:03AM	The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings Benzinga
Dec-07-20 08:05AM	Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM Real-World Platform in Metastatic Breast Cancer Business Wire
Nov-27-20 06:09AM	Got $3,000? 3 Growth Stocks to Buy That Could Skyrocket Motley Fool +5.34%
Nov-16-20 11:22PM	Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering Business Wire -10.18%
06:45PM	Why Guardant Health Tumbled by Over 10% on Monday Motley Fool
06:47AM	Guardant Health, Inc. Announces Proposed Convertible Senior Notes Offering Business Wire
Nov-13-20 08:30AM	Wild Ride For Illumina Stock Shows Promise, Challenge Of Multi-Cancer Blood Tests Investor's Business Daily
Nov-07-20 09:43AM	Here's What Analysts Are Forecasting For Guardant Health, Inc. (NASDAQ:GH) After Its Third-Quarter Results Simply Wall St.
06:30AM	Better Coronavirus Stock: Quidel or Guardant Health? Motley Fool
12:31AM	Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 05:25PM	Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:03PM	Guardant Health Reports Third Quarter 2020 Financial Results Business Wire
Nov-03-20 10:12AM	Were Hedge Funds Right About Loading Up On Guardant Health, Inc. (GH)? Insider Monkey
Oct-30-20 09:42AM	We're Not Worried About Guardant Health's (NASDAQ:GH) Cash Burn Simply Wall St.
Oct-29-20 12:35PM	Analysts Estimate Guardant Health (GH) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-27-20 03:03PM	Why Exact Sciences $2.15 Billion Deal Has Investors Excited About Cancer-Screening Technology Barrons.com +8.54%
12:03PM	Guardant Health Soars Investor's Business Daily Video
Oct-17-20 07:14AM	Is Guardant Health Stock a Buy? Motley Fool
Oct-16-20 04:05PM	Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 Business Wire
Oct-15-20 04:05PM	Guardant Health Announces Closing of Public Offering of Common Stock, Including Option to Purchase Additional Shares by Selling Stockholder Business Wire
06:01AM	Investing in These 3 Stocks Now Could Make You a Millionaire Retiree Motley Fool
Oct-12-20 08:14AM	Market Crash 2.0: Where to Invest $1,000 Motley Fool
06:04AM	3 Game-Changing Stocks to Buy and Hold for the Next 20 Years Motley Fool
Oct-07-20 03:14PM	Guardant Health Dips on Pricing of Equity Offering Motley Fool
10:22AM	Return On Capital Employed Overview: Guardant Health Benzinga
09:06AM	Guardant Health Announces Pricing of Public Offering of Common Stock by Selling Stockholder Business Wire
Oct-06-20 04:54PM	Guardant Health Announces Proposed Public Offering of Common Stock by Selling Stockholder Business Wire
Oct-05-20 04:05PM	Large-Scale Study Shows Guardant360 Liquid Biopsy Accelerates Clinical Trial Enrollment Compared to Tissue Biopsy Business Wire
Sep-29-20 12:37PM	Healthcare Services Stocks Positioned for Move Higher Investopedia
07:27AM	Is Exact Sciences a Good Healthcare Stock to Buy Now? Motley Fool
06:30AM	Has Guardant Health Lived Up to the Hype? Motley Fool
Sep-26-20 06:16AM	If You Invested $10,000 in Guardant Health's IPO, This Is How Much Money You'd Have Today Motley Fool
Sep-21-20 04:27PM	Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail Investor's Business Daily
Sep-16-20 06:19AM	3 Great Stocks With Better Growth Prospects Than Tesla to Buy Motley Fool
Sep-15-20 08:17AM	Dow Jones Futures: Stock Market Rally Gets A Win, Apple In Buy Zone; Tesla Rival Nikola Sinks On SEC Probe Investor's Business Daily
Sep-11-20 02:10PM	Hedge Funds Keep Piling Into Guardant Health, Inc. (GH) Insider Monkey
Sep-09-20 03:54PM	Grail, Backed by Jeff Bezos and Bill Gates, Files for IPO Motley Fool
Sep-03-20 06:08AM	3 Game-Changing Stocks That Are Better Buys Than Tesla Motley Fool
Sep-01-20 04:03PM	Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference GlobeNewswire
07:00AM	Got $3,000? Here Are 3 Stocks That Could Double Your Money -- and Sooner Than You Might Think Motley Fool
Aug-29-20 08:00AM	Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise Investor's Business Daily
Aug-28-20 06:08AM	Investing $3,000 in These 3 Stocks Could Make You a Fortune Over the Next Decade Motley Fool
Aug-26-20 07:09AM	Optimistic That You'll Get a Second Stimulus Check? Plan to Invest It in These 3 Stocks Motley Fool
Aug-24-20 04:15PM	Guardant Health Coronavirus Test Gets Emergency OK Investor's Business Daily
08:05AM	Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 Next Generation Sequencing-Based COVID-19 Test GlobeNewswire
Aug-11-20 06:40AM	SoftBank Moves Into Asset Management After Return to Profits Bloomberg -5.00%
Aug-10-20 01:24PM	If You Had Bought Guardant Health's (NASDAQ:GH) Shares A Year Ago You Would Be Down 13% Simply Wall St.
08:05AM	Guardant Health to Participate in Upcoming August Investor Conferences GlobeNewswire
Aug-07-20 02:25PM	Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers GlobeNewswire
Aug-06-20 08:30PM	Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:07PM	Sons SoftBank Poised to Return to Profit After Big Losses Bloomberg
04:03PM	Guardant Health Reports Second Quarter 2020 Financial Results GlobeNewswire
Aug-02-20 06:46AM	3 Healthcare Stocks That Could Make You Rich Motley Fool
Jul-30-20 04:10PM	Guardant Health Announces Collaboration with Radius Health to Develop Liquid Biopsy Companion Diagnostic for Elacestrant GlobeNewswire
12:33PM	Analysts Estimate Guardant Health (GH) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-26-20 07:08AM	$10,000 Invested in These Growth Stocks Could Make You a Fortune Motley Fool
Jul-22-20 11:30AM	Is Guardant Health (GH) Outperforming Other Medical Stocks This Year? Zacks
Jul-21-20 08:05AM	Guardant Health Announces Webcast of Second Quarter Financial Results on August 6, 2020 GlobeNewswire
Jul-19-20 07:03AM	Got $5,000? 3 Brilliant Stocks to Buy Right Now Motley Fool
Jul-17-20 08:00AM	How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market Investor's Business Daily
Jul-13-20 01:12PM	Why Guardant Health (GH) is an Incredible Growth Stock? Insider Monkey -5.74%
Jul-12-20 07:37PM	Did Hedge Funds Make The Right Call On Guardant Health, Inc. (GH)? Insider Monkey
Jul-08-20 12:09PM	Here's Why Guardant Health Dropped 10.2% in June Motley Fool
08:05AM	Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic GlobeNewswire
Jul-05-20 07:07AM	Buying These 3 Stocks Could Make You Crazy Rich Motley Fool
Jul-02-20 09:03AM	10 Stocks to Invest in the Health Care Revolution Kiplinger
Jun-23-20 07:55AM	Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology Drug Development GlobeNewswire
Jun-22-20 09:05AM	Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liquid Biopsy Highly Accurate in Detecting Early-Stage Colorectal Cancer GlobeNewswire +5.30%
Jun-16-20 04:30PM	Guardant Health Appoints Vijaya Gadde to its Board of Directors GlobeNewswire
Jun-14-20 07:08AM	Buying These 3 Stocks Is a Brilliant Move to Make Right Now Motley Fool
Jun-13-20 08:10AM	Could Guardant Health Be a Millionaire-Maker Stock? Motley Fool
Jun-12-20 11:42AM	Largest Insider Trades of the Week GuruFocus.com
Jun-08-20 04:03PM	Guardant Health Announces Full Exercise of Option and Closing of Public Offering GlobeNewswire
02:50PM	Hedge Funds Arent Crazy About Guardant Health, Inc. (GH) Anymore Insider Monkey
Jun-01-20 10:32PM	Guardant Health Announces Pricing of Upsized Public Offering GlobeNewswire
04:37PM	Guardant Health Announces Proposed Public Offering of Common Stock GlobeNewswire
May-29-20 04:03PM	Guardant Health to Participate in the William Blair 2020 Growth Stock Conference GlobeNewswire
May-23-20 07:45AM	Investing $5,000 in These 3 Stocks Could Make You a Fortune Over the Next 10 Years Motley Fool
May-15-20 08:05AM	Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Biopsy for Precision Oncology in Advanced and Early Stage Cancer GlobeNewswire +5.49%
May-09-20 05:01PM	Guardant Health Inc (GH) Q1 2020 Earnings Call Transcript Motley Fool
May-08-20 04:27PM	Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable' Investor's Business Daily +5.00%
10:27AM	Will Guardant Health Continue to Surge Higher? Zacks
May-07-20 04:03PM	Guardant Health Reports First Quarter 2020 Financial Results GlobeNewswire
09:51AM	Zacks.com featured highlights include: Activision Blizzard, Guardant Health, Vertex Pharmaceuticals, Aphria and Shopify Zacks
May-06-20 04:03PM	Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference GlobeNewswire
09:45AM	5 Top-Ranked Stocks to Tap Earnings Beat Potential Zacks
May-05-20 08:05AM	Guardant Health and Patient Advocacy Groups Join Forces to Raise Awareness of the Importance of Complete Biomarker Testing for Patients with Metastatic Non-Small Cell Lung Cancer GlobeNewswire +5.36%
07:01AM	Have $1,000? Consider Investing It in 1 of These Hot Growth Stocks Motley Fool

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Eltoukhy Helmy	Chief Executive Officer	Jan 21	Sale	162.01	173,206	28,061,525	2,788,649	Jan 21 07:46 PM
Eltoukhy Helmy	Chief Executive Officer	Jan 20	Sale	163.53	167,663	27,418,473	2,961,855	Jan 21 07:46 PM
Eltoukhy Helmy	Chief Executive Officer	Jan 20	Sale	163.53	44,528	7,281,807	365,775	Jan 21 07:46 PM
Eltoukhy Helmy	Chief Executive Officer	Jan 19	Sale	160.12	103,717	16,606,912	410,303	Jan 21 07:46 PM
Eltoukhy Helmy	Chief Executive Officer	Jan 15	Sale	158.39	150,000	23,758,873	514,020	Jan 19 04:59 PM
MERESMAN STANLEY J	Director	Jan 11	Option Exercise	5.94	4,934	29,308	8,993	Jan 13 04:40 PM
MERESMAN STANLEY J	Director	Jan 11	Sale	142.00	4,934	700,628	4,059	Jan 13 04:40 PM
CLARK IAN T	Director	Jan 04	Option Exercise	4.18	2,690	11,244	7,333	Jan 06 04:18 PM
CLARK IAN T	Director	Jan 04	Sale	129.23	2,690	347,629	4,643	Jan 06 04:18 PM
Talasaz AmirAli	Chairman, President and COO	Jan 01	Option Exercise	0.00	565,192	0	3,128,647	Jan 05 08:42 PM
Eltoukhy Helmy	Chief Executive Officer	Jan 01	Option Exercise	0.00	565,192	0	3,408,645	Jan 05 08:44 PM
CLARK IAN T	Director	Dec 28	Option Exercise	4.18	538	2,249	5,181	Dec 30 04:30 PM
CLARK IAN T	Director	Dec 28	Sale	135.00	538	72,630	4,643	Dec 30 04:30 PM
Talasaz AmirAli	Chairman, President and COO	Dec 21	Option Exercise	4.18	23,923	99,998	2,563,455	Dec 23 04:50 PM
Eltoukhy Helmy	Chief Executive Officer	Dec 16	Option Exercise	4.18	23,923	99,998	2,843,453	Dec 18 04:57 PM
MERESMAN STANLEY J	Director	Dec 10	Option Exercise	5.94	4,954	29,427	9,013	Dec 14 04:52 PM
MERESMAN STANLEY J	Director	Dec 10	Sale	125.44	4,954	621,430	4,059	Dec 14 04:52 PM
CLARK IAN T	Director	Dec 03	Option Exercise	4.18	2,690	11,244	7,333	Dec 07 05:01 PM
CLARK IAN T	Director	Dec 03	Sale	120.00	2,690	322,800	4,643	Dec 07 05:01 PM
CLARK IAN T	Director	Nov 25	Option Exercise	4.18	538	2,249	5,181	Nov 27 02:48 PM
CLARK IAN T	Director	Nov 25	Sale	113.28	538	60,945	4,643	Nov 27 02:48 PM
MERESMAN STANLEY J	Director	Nov 10	Option Exercise	5.94	5,000	29,700	9,059	Nov 12 05:07 PM
MERESMAN STANLEY J	Director	Nov 10	Sale	110.30	5,000	551,500	4,059	Nov 12 05:07 PM
CLARK IAN T	Director	Nov 03	Option Exercise	4.18	2,690	11,244	7,333	Nov 05 05:32 PM
CLARK IAN T	Director	Nov 03	Sale	105.28	2,690	283,203	4,643	Nov 05 05:32 PM
Talasaz AmirAli	Chairman, President and COO	Oct 27	Sale	107.18	75,851	8,129,541	620,800	Oct 27 06:08 PM
CLARK IAN T	Director	Oct 26	Option Exercise	4.18	538	2,249	5,181	Oct 28 04:32 PM
Talasaz AmirAli	Chairman, President and COO	Oct 26	Sale	105.02	4,613	484,472	696,651	Oct 27 06:08 PM
CLARK IAN T	Director	Oct 26	Sale	104.03	538	55,968	4,643	Oct 28 04:32 PM
Talasaz AmirAli	Chairman, President and COO	Oct 23	Sale	105.15	13,136	1,381,315	701,264	Oct 27 06:08 PM
Talasaz AmirAli	Chairman, President and COO	Oct 16	Sale	102.44	23,400	2,397,132	714,400	Oct 20 04:20 PM
Kaul Samir	Director	Oct 16	Sale	101.88	10,000	1,018,793	51,943	Oct 20 04:20 PM
MERESMAN STANLEY J	Director	Oct 12	Option Exercise	5.94	5,000	29,700	9,059	Oct 14 04:48 PM
MERESMAN STANLEY J	Director	Oct 12	Sale	109.37	5,000	546,850	4,059	Oct 14 04:48 PM
SVF Bluebird (Cayman) Ltd	10% Owner	Oct 09	Sale	101.08	7,000,000	707,574,000	7,037,960	Oct 13 06:40 PM
CLARK IAN T	Director	Oct 05	Option Exercise	4.18	2,690	11,244	7,333	Oct 05 08:55 PM
CLARK IAN T	Director	Oct 05	Sale	108.50	2,690	291,865	4,643	Oct 05 08:55 PM
CLARK IAN T	Director	Sep 25	Option Exercise	4.18	538	2,249	5,181	Oct 05 08:55 PM
Talasaz AmirAli	Chairman, President and COO	Sep 25	Sale	110.71	75,000	8,303,375	2,539,532	Sep 29 05:01 PM
CLARK IAN T	Director	Sep 25	Sale	106.24	538	57,157	4,643	Oct 05 08:55 PM
Eltoukhy Helmy	Chief Executive Officer	Sep 18	Option Exercise	4.18	13,630	56,973	2,884,952	Sep 22 04:39 PM
Eltoukhy Helmy	Chief Executive Officer	Sep 18	Sale	102.09	65,422	6,679,062	2,819,530	Sep 22 04:39 PM
Eltoukhy Helmy	Chief Executive Officer	Sep 17	Option Exercise	4.18	42,921	179,410	3,077,343	Sep 17 09:10 PM
Eltoukhy Helmy	Chief Executive Officer	Sep 17	Sale	100.59	206,021	20,722,636	2,871,322	Sep 17 09:10 PM
Kaul Samir	Director	Sep 17	Sale	100.83	10,000	1,008,264	61,943	Sep 21 05:18 PM
Eltoukhy Helmy	Chief Executive Officer	Sep 16	Option Exercise	4.18	45,523	190,286	3,252,931	Sep 17 09:10 PM
Eltoukhy Helmy	Chief Executive Officer	Sep 16	Sale	103.92	218,509	22,707,933	3,034,422	Sep 17 09:10 PM
Eltoukhy Helmy	Chief Executive Officer	Sep 15	Option Exercise	4.18	22,926	95,831	3,317,456	Sep 17 09:10 PM
Eltoukhy Helmy	Chief Executive Officer	Sep 15	Sale	103.22	110,048	11,359,063	3,207,408	Sep 17 09:10 PM
MERESMAN STANLEY J	Director	Sep 10	Option Exercise	5.94	5,000	29,700	9,059	Sep 14 05:06 PM
MERESMAN STANLEY J	Director	Sep 10	Sale	94.22	5,000	471,100	4,059	Sep 14 05:06 PM
CLARK IAN T	Director	Sep 08	Option Exercise	4.18	9,146	38,230	13,789	Sep 10 05:24 PM
CLARK IAN T	Director	Sep 08	Sale	89.25	9,146	816,247	4,643	Sep 10 05:24 PM
Talasaz AmirAli	Chairman, President and COO	Sep 02	Sale	94.15	75,000	7,060,961	2,614,532	Sep 04 05:20 PM
BERTOCCI DEREK A	Chief Financial Officer	Sep 01	Sale	93.94	30,100	2,827,454	6,373	Sep 03 05:13 PM
BERTOCCI DEREK A	Chief Financial Officer	Aug 24	Option Exercise	4.82	9,992	48,193	46,465	Aug 26 04:57 PM
BERTOCCI DEREK A	Chief Financial Officer	Aug 24	Sale	94.39	9,992	943,102	36,473	Aug 26 04:57 PM
BERTOCCI DEREK A	Chief Financial Officer	Aug 17	Sale	87.76	25,000	2,194,005	36,473	Aug 19 05:37 PM
Kaul Samir	Director	Aug 17	Sale	87.58	10,000	875,848	71,943	Aug 19 05:37 PM
MERESMAN STANLEY J	Director	Aug 10	Option Exercise	5.94	5,000	29,700	9,059	Aug 12 05:06 PM
MERESMAN STANLEY J	Director	Aug 10	Sale	87.00	5,000	435,000	4,059	Aug 12 05:06 PM
Talasaz AmirAli	Chairman, President and COO	Aug 04	Option Exercise	4.18	15,000	62,700	2,704,532	Aug 05 04:55 PM
Talasaz AmirAli	Chairman, President and COO	Aug 04	Sale	84.19	15,000	1,262,877	2,689,532	Aug 05 04:55 PM
Talasaz AmirAli	Chairman, President and COO	Aug 03	Option Exercise	4.18	60,000	250,800	2,749,532	Aug 05 04:55 PM
Talasaz AmirAli	Chairman, President and COO	Aug 03	Sale	86.26	60,000	5,175,768	2,689,532	Aug 05 04:55 PM
MERESMAN STANLEY J	Director	Jul 10	Option Exercise	5.94	6,000	35,640	10,059	Jul 14 05:00 PM
MERESMAN STANLEY J	Director	Jul 10	Sale	86.66	6,000	519,960	4,059	Jul 14 05:00 PM
Talasaz AmirAli	Chairman, President and COO	Jul 06	Option Exercise	4.18	20,108	84,051	2,709,640	Jul 06 08:12 PM
Talasaz AmirAli	Chairman, President and COO	Jul 06	Sale	84.10	20,108	1,691,001	2,689,532	Jul 06 08:12 PM
Talasaz AmirAli	Chairman, President and COO	Jul 02	Option Exercise	4.18	54,892	229,449	2,744,424	Jul 06 08:12 PM
Talasaz AmirAli	Chairman, President and COO	Jul 02	Sale	83.87	54,892	4,603,794	2,689,532	Jul 06 08:12 PM
CLARK IAN T	Director	Jun 25	Option Exercise	4.18	538	2,249	5,181	Jun 29 05:59 PM
CLARK IAN T	Director	Jun 25	Sale	81.27	538	43,723	4,643	Jun 29 05:59 PM
MERESMAN STANLEY J	Director	Jun 10	Option Exercise	5.94	6,000	35,640	7,302	Jun 12 05:08 PM
MERESMAN STANLEY J	Director	Jun 10	Sale	80.59	6,000	483,540	1,302	Jun 12 05:08 PM
SVF Bluebird (Cayman) Ltd	10% Owner	Jun 08	Sale	83.16	1,162,500	96,673,500	14,037,960	Jun 08 08:23 PM
SVF Bluebird (Cayman) Ltd	10% Owner	Jun 04	Sale	83.16	7,750,000	644,490,000	15,200,460	Jun 08 08:23 PM
Talasaz AmirAli	Chairman, President and COO	Jun 03	Option Exercise	4.18	55,000	229,900	2,744,532	Jun 04 04:46 PM
CLARK IAN T	Director	Jun 03	Option Exercise	4.18	2,690	11,244	3,992	Jun 05 05:03 PM
CLARK IAN T	Director	Jun 03	Sale	87.52	2,690	235,429	1,302	Jun 05 05:03 PM
Talasaz AmirAli	Chairman, President and COO	Jun 03	Sale	85.63	55,000	4,709,402	2,689,532	Jun 04 04:46 PM
Talasaz AmirAli	Chairman, President and COO	Jun 02	Option Exercise	4.18	20,000	83,600	2,709,532	Jun 04 04:46 PM
Talasaz AmirAli	Chairman, President and COO	Jun 02	Sale	87.63	20,000	1,752,673	2,689,532	Jun 04 04:46 PM
CLARK IAN T	Director	May 26	Option Exercise	4.18	538	2,249	1,840	May 26 05:16 PM
CLARK IAN T	Director	May 26	Sale	98.50	538	52,993	1,302	May 26 05:16 PM
BERTOCCI DEREK A	Chief Financial Officer	May 22	Option Exercise	4.49	9,222	41,422	71,409	May 26 05:17 PM
BERTOCCI DEREK A	Chief Financial Officer	May 22	Sale	96.63	9,222	891,146	62,187	May 26 05:17 PM
Nishar Dipchand	Director	May 18	Sale	100.00	2	200	2,321	May 20 05:16 PM
Talasaz AmirAli	Chairman, President and COO	May 11	Option Exercise	4.18	6,000	25,080	2,889,483	May 11 06:45 PM
MERESMAN STANLEY J	Director	May 11	Option Exercise	5.94	6,500	38,610	7,802	May 13 05:00 PM
MERESMAN STANLEY J	Director	May 11	Sale	86.50	6,500	562,250	1,302	May 13 05:00 PM
Talasaz AmirAli	Chairman, President and COO	May 11	Sale	91.68	199,951	18,332,329	2,689,532	May 11 06:45 PM
BERTOCCI DEREK A	Chief Financial Officer	May 11	Sale	92.53	21,862	2,022,891	62,187	May 12 05:02 PM
Talasaz AmirAli	Chairman, President and COO	May 08	Option Exercise	4.18	750	3,135	2,908,532	May 11 06:45 PM
Talasaz AmirAli	Chairman, President and COO	May 08	Sale	90.13	25,049	2,257,641	2,883,483	May 11 06:45 PM
BERTOCCI DEREK A	Chief Financial Officer	May 08	Sale	90.40	913	82,533	84,049	May 12 05:02 PM
Talasaz AmirAli	Chairman, President and COO	May 07	Option Exercise	4.18	1,762	7,365	2,981,195	May 11 06:45 PM
Talasaz AmirAli	Chairman, President and COO	May 07	Sale	83.38	73,413	6,121,005	2,907,782	May 11 06:45 PM
Talasaz AmirAli	Chairman, President and COO	May 06	Option Exercise	4.18	2,400	10,032	3,079,433	May 06 06:20 PM
Talasaz AmirAli	Chairman, President and COO	May 06	Sale	81.24	100,000	8,123,659	2,979,433	May 06 06:20 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience